Business Description
Hologic Inc
NAICS : 334517
SIC : 3844
ISIN : US4364401012
Share Class Description:
MEX:HOLX: Ordinary SharesDescription
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.88 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 2.05 | |||||
| Interest Coverage | 7.62 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.05 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.9 | |||||
| 3-Year EBITDA Growth Rate | -20.9 | |||||
| 3-Year EPS without NRI Growth Rate | -17.6 | |||||
| 3-Year FCF Growth Rate | -16.4 | |||||
| 3-Year Book Growth Rate | 10 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.56 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.69 | |||||
| Quick Ratio | 3.03 | |||||
| Cash Ratio | 2.25 | |||||
| Days Inventory | 131.45 | |||||
| Days Sales Outstanding | 57.46 | |||||
| Days Payable | 39.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3 | |||||
| Shareholder Yield % | 6.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.28 | |||||
| Operating Margin % | 23.1 | |||||
| Net Margin % | 19.59 | |||||
| FCF Margin % | 28.71 | |||||
| ROE % | 16.05 | |||||
| ROA % | 8.9 | |||||
| ROIC % | 14.27 | |||||
| ROC (Joel Greenblatt) % | 84.13 | |||||
| ROCE % | 12.57 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.77 | |||||
| Forward PE Ratio | 14.05 | |||||
| PE Ratio without NRI | 17.16 | |||||
| Shiller PE Ratio | 24.63 | |||||
| Price-to-Owner-Earnings | 17.5 | |||||
| PEG Ratio | 0.88 | |||||
| PS Ratio | 4.27 | |||||
| PB Ratio | 3.27 | |||||
| Price-to-Tangible-Book | 19.92 | |||||
| Price-to-Free-Cash-Flow | 15.02 | |||||
| Price-to-Operating-Cash-Flow | 13.38 | |||||
| EV-to-EBIT | 16.91 | |||||
| EV-to-Forward-EBIT | 14.97 | |||||
| EV-to-EBITDA | 12.87 | |||||
| EV-to-Forward-EBITDA | 14.11 | |||||
| EV-to-Revenue | 4.15 | |||||
| EV-to-Forward-Revenue | 4.46 | |||||
| EV-to-FCF | 14.48 | |||||
| Price-to-Projected-FCF | 1.06 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.29 | |||||
| Price-to-Graham-Number | 3.9 | |||||
| Earnings Yield (Greenblatt) % | 5.91 | |||||
| FCF Yield % | 6.91 | |||||
| Forward Rate of Return (Yacktman) % | 20.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hologic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 72,248.88 | ||
| EPS (TTM) (MXN) | 59.595 | ||
| Beta | 0.06 | ||
| Volatility % | 3.65 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 1207.71 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 1207.71 - 1207.71 | ||
| Shares Outstanding (Mil) | 226.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hologic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hologic Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hologic Inc Frequently Asked Questions
What is Hologic Inc(MEX:HOLX)'s stock price today?
The current price of MEX:HOLX is MXN1207.71. The 52 week high of MEX:HOLX is MXN1207.71 and 52 week low is MXN1207.71.
When is next earnings date of Hologic Inc(MEX:HOLX)?
The next earnings date of Hologic Inc(MEX:HOLX) is 2025-01-31 Est..
Does Hologic Inc(MEX:HOLX) pay dividends? If so, how much?
Hologic Inc(MEX:HOLX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers